CognivyaAI is an AI-native therapeutics company focused on discovering and developing proprietary medicines.
We are building a differentiated portfolio across multiple modalities and therapeutic areas, informed by advances in artificial intelligence and computational science.
Building a New Kind of Therapeutics Company
CognivyaAI is being built around a simple conviction: the next generation of therapeutics will emerge from a deeper integration of science, computation, and drug-development expertise.
We are applying this perspective to the creation of proprietary therapeutic assets, with an emphasis on differentiated opportunities where thoughtful design and rigorous decision-making can create meaningful value.
